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Objectives To evaluate the ability of quantitative perfusion cardiac magnetic resonance (CMR) to assess the hemodynamic
significance of coronary artery disease (CAD) compared with well-established anatomic and physiologic
techniques.
Background Fractional flow reserve (FFR) is considered by many investigators to be a reliable stenosis-specific method to
determine hemodynamically significant CAD. Quantitative perfusion CMR is a promising noninvasive approach to
detect CAD but has yet to be validated against FFR.
Methods This is a prospective study in patients with suspected CAD who underwent coronary angiography, FFR, and CMR
assessments. The quantitative myocardial perfusion reserve (MPR) was calculated in 720 myocardial sectors (8
sectors/slice). The MPR was calculated from the ratio between stress and rest myocardial flow based on signal
intensity time curves using deconvolution analysis. Stress was simulated with adenosine for both FFR and MPR.
The MPR assessments were compared to FFR (n  44 coronary segments) and quantitative coronary angiogra-
phy (n  108 segments) in the corresponding coronary territories.
Results The MPR was 1.54  0.36 in segments with FFR 0.75 (n  14) and 2.11  0.68 in those with FFR 0.75
(n  30; p  0.0054). An MPR cutoff of 2.04 was 92.9% (95% CI 77.9 to 100.0) sensitive and 56.7% (95% CI
32.8 to 80.6) specific in predicting a coronary segment with FFR 0.75. The MPR was 1.54  0.49 in coronary
segments with 50% diameter stenosis (DS) (n  47) and 2.13  0.80 in segments with 50% DS (n  61;
p  0.001). An MPR cutoff of 2.04 was 85.1% (95% CI 71.1 to 99.2) sensitive and 49.2% (95% CI 33.6 to 64.8)
specific in predicting CAD with 50% DS.
Conclusions Quantitative perfusion CMR is a safe noninvasive test that represents a stenosis-specific alternative to de-
termine the hemodynamic significance of CAD. (J Am Coll Cardiol 2007;50:514–22) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.04.053m
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pn patients with coronary artery disease (CAD), revascular-
zation is deemed appropriate based on combined physio-
ogic and anatomic data. Quantitative coronary angiography
QCA) remains a well-established technique in the ana-
omic assessment of CAD (1,2), whereas fractional flow
eserve (FFR) is an accurate stenosis-specific method to
valuate the hemodynamic significance of CAD (3,4). Both
rom the *Division of Cardiology and the †Division of Radiology, University of
lorida Shands Jacksonville, Jacksonville, Florida.r
Manuscript received August 1, 2006; revised manuscript received February 7, 2007,
ccepted April 3, 2007.ethods are well validated and routinely applied to deter-
ine severity of CAD (1,5,6). However, the invasive nature
f these diagnostic modalities limits their broad application
or screening purposes.
Cardiac magnetic resonance (CMR) is a promising non-
nvasive and ionizing-free radiation imaging modality to
valuate CAD. The first pass of gadolinium through the
yocardium can be plotted as signal intensity (SI) versus
ime. Both relative and absolute blood flows can be quan-
ified with reproducibility by first-pass magnetic resonance
erfusion (7,8). The high spatial resolution of CMR allows
egional quantification of transmural flow gradients (9).
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August 7, 2007:514–22 Quantitative Perfusion CMR Versus FFR to Assess CADyocardial perfusion reserve (MPR) can be calculated from
he ratio of simulated stress and rest flows derived from the
yocardial SI time curves.
Perfusion CMR has compared favorably with other
oninvasive modalities to detect CAD (10–13). Pilot stud-
es have shown the correlation between CMR and invasive
ssessment of coronary flow reserve (CFR) using intracoro-
ary Doppler flow wire or positron emission tomography
8,10,14). However, CFR is highly influenced by the micro-
irculation status and is not considered a stenosis-specific
ethod to define the hemodynamic significance of CAD
15,16). As a result, CFR has been replaced by FFR as the
entral invasive physiologic technique to define CAD severity.
hether perfusion CMR correlates with FFR and represents
noninvasive stenosis-specific assessment of ischemia and
emodynamically significant stenoses remains to be evaluated.
The present study investigated the ability of CMR to
ssess the physiologic significance of CAD. We compared
uantitative perfusion CMR using MPR with stenosis-
pecific physiologic assessments determined by FFR and
natomic assessments by QCA.
ethods
e prospectively enrolled 37 consecutive patients, between
8 and 80 years of age, with suspected CAD who under-
ent coronary angiography, FFR, and CMR assessments.
atients were excluded if they had a myocardial infarction
ithin 14 days of either procedure, high-degree atrioven-
ricular block, hypotension (systolic blood pressure90 mm
g), severe chronic obstructive pulmonary disease, decom-
ensated congestive heart failure (New York Heart Associ-
tion functional class III or IV), a ferromagnetic metallic
mplant, or claustrophobia or were pregnant or lactating. All
MR assessments were done within 2 months of the
ngiography and FFR evaluations. Coronary revasculariza-
ion was not performed between CMR and angiography
ssessments. The protocol was approved by the institutional
eview board. Informed consent was obtained before study
rocedures.
ngiography and fractional flow reserve assessments.
uiding catheters (6-F) without side holes were used. Cine
ngiographies were performed in at least 2 orthogonal
rojections after 100 to 200 g intracoronary nitroglycerin
nfusion. All cineangiographies were recorded on digital
ompact discs. The QCA was performed off line by an
ndependent core laboratory (University of Florida Cardio-
ascular Imaging Core Laboratories, Jacksonville, Florida).
nterpolated reference vessel diameter, minimal lumen di-
meter, and percentage diameter stenosis (DS) were calcu-
ated using an automated contour detection algorithm
CAAS II Analysis System, Pie Medical, Maastricht, the
etherlands) with at least 2 orthogonal angiographic views.
straight (nontapered) portion of the catheter was used for
mage calibration. Measurements were performed by an
ndependent analyst who was blinded to the clinical, FFR,
nd MPR data. Side branches distal and proximal to the stenotic segment were used to
efine the target segment for
uantitative analysis. This meth-
dology has been found to be
ighly accurate (0.01  0.18
m) and reproducible (correla-
ion coefficient 0.94) (17). The
CA was performed in all 3
ajor epicardial coronary arteries
n each patient, regardless of the
isual estimation of stenosis.
Intracoronary pressure was
easured using a 0.014-inch
ressure guide wire (WaveMap
ressure System; Volcano Ther-
peutics, Rancho Cordova, Cali-
ornia) across the target stenosis.
he ratio of the distal and the
ortic pressure on maximal hy-
eremia, or pressure-derived
ractional flow reserve (FFR 
d/Pa), has been extensively validated (3,4). Following 100
o 200 g of intracoronary nitroglycerin injection, FFR was
alculated after intravenous adenosine at 140 g/kg/min for
t least 2 min. All measurements, as well as calibration,
ressure equalization, baseline and hyperemic trans-stenotic
radients, and FFR were recorded. The stenosis was con-
idered physiologically significant if the FFR was0.75 (3).
MR quantification of myocardial perfusion reserve.
ontrast-enhanced magnetic resonance imaging (MRI) us-
ng gadolinium-based contrast agents has been used to
valuate myocardial perfusion patterns (18,19). Imaging
ostprocessing was performed using commercial worksta-
ions (Leonardo, Siemens, Munich, Germany; and Mass
low MR 6.1, Medis, Leiden, the Netherlands). In the
resent study, SI time curve editing was performed using a
edicated workstation (Mass Flow, version 6.1, Medis),
hich allowed objective and automated assessment of myo-
ardial SI time curves to derive myocardial blood flow data
ith minimal interference by the analyst. Measurements
ere performed by 2 independent MRI experts blinded to
he angiographic and FFR results. Adequate CMR image
uality for quantification was prospectively determined by
valuating the contrast injection, image resolution, and SI
urve. Quantification requires a very rapid bolus by a power
njector that ideally forms a single sharp spike occurring at
ime zero. Spatial resolution should be 2.5 mm to resolve
ransmural variations in blood flow. Temporal resolution
hould be 1 to 2 image frames per heartbeat. The SI curve
or each sector should be compared with the wash-in curve
f the left ventricular (LV) blood pool, looking for the
haracteristic upslope and delayed and reduced peak signal
mplitude.
After manual correction of images for gross cardiac
otion, endocardial and epicardial contours were drawn to
efine the myocardium for the base, middle, and apical
Abbreviations
and Acronyms
CAD  coronary artery
disease
CFR  coronary flow
reserve
CI  confidence interval
CMR  cardiac magnetic
resonance
DS  diameter stenosis
FFR  fractional flow
reserve
LV  left
ventricle/ventricular
MPR  myocardial
perfusion reserve
QCA  quantitative
coronary angiography
SI  signal intensitylices. The myocardium was then segmented into 8 equi-
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rdered in a clockwise orientation, with sector number 1
eginning at the insertion of the right ventricle to the
nterior septal wall of the LV. The distribution of the
rterial territories within the 24 segments was based on
he 17-segment model for tomographic imaging of the heart
20). The left anterior descending artery perfusion territory
as assigned to sectors 8, 1, and 2 for the base, middle, and
pical slices. The diagonal branches perfusion territory was
ssigned to sectors 1 and 2 for the middle and apical slices.
he circumflex artery and obtuse marginal branches perfu-
ion territories were assigned to sectors 3 and 4. The
ircumflex territory included the base, middle, and apical
lices, and the obtuse marginal branches territory involved
he middle and apical slices. The right coronary artery and
osterior descending artery perfusion territories were as-
igned to sectors 5, 6, and 7. The right coronary artery
erritory included the base, middle, and apical slices, and the
osterior descending artery territory was assigned to the
pical slice. The posterior lateral artery perfusion territory
Figure 1 Base, Middle, And Apical Short-Axis CMR Slices Divid
(Lower right panel) Schematic representation of the 3 concentric left ventricle sho
diac magnetic resonance (CMR) images represents the anterior insertion of the rig
descending (base 1, 2, 8; middle 9, 10, 16; apical 17, 18, 24), diagonal branche
obtuse marginal branches (middle 11, 12; apical 19, 20), right coronary (base 5,
and posterior lateral (apical 20,21) arteries.as assigned to sectors 4 and 5 of the apical slice (Fig. 1). CConstrained deconvolution analysis using a Fermi func-
ion was applied to the first-pass SI curves and provided an
djusted or absolute myocardial blood flow measurement
sing a custom C software program previously devel-
ped by our group (7–9). The Fermi function models the
robability that a contrast molecule has left the myocardium
s a function of time. Deconvolution of the LV blood pool
I curve with the Fermi function yields a theoretic myocar-
ial SI curve. The theoretic curve is compared against the
ctual measured myocardial SI data points using least
quares and a repetitive Marquardt-Levenberg algorithm.
he initial amplitude of the Fermi function corresponds to
bsolute myocardial blood flow (21–24). This technique has
een validated using radioactive microspheres (25). The
PR was then calculated as the ratio of myocardial blood
ow at maximal hyperemia divided by the myocardial blood
ow at rest. The MPR was then normalized by rate pressure
roduct, which was calculated for rest and hyperemia at the
aximum rate of adenosine infusion, as previously de-
cribed and validated (7,21,24,25). The reproducibility of
to 8 Equidistant Radial Sectors
slices segmented radially on a polar map. The plus () sign in blue in the car-
tricle. The segments were assigned based on anatomic location of left anterior
dle 9, 10; apical 17, 18), circumflex (base 3, 4; middle 11, 12; apical 19, 20),
iddle 13, 14, 15; apical 21, 22, 23), posterior descending (apical 21, 22, 23),ed In
rt-axis
ht ven
s (mid
6, 7; mMR first-pass imaging has also been reported and showed
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August 7, 2007:514–22 Quantitative Perfusion CMR Versus FFR to Assess CADood intraobserver (correlation coefficient  0.8 to 0.85)
nd interobserver (correlation coefficient  0.81 to 0.97)
greements (26).
MR imaging protocol. All patients underwent first-pass
ontrast-enhanced CMR perfusion analysis imaging ob-
ained at rest and stress on a Sonata 1.5 Tesla (Siemens-
onata) magnet (maximum slew rate 150 T/m/s: gradient
trength 40 mT/m) using a 6-channel body coil. Scout
mages were obtained initially to determine the cardiac
eometry and to plan subsequent scans. Imaging was per-
ormed at rest and simulated stress during intravenous
njection of 0.1-mmol/kg gadolinium-DPTA (Magnevist;
erlex Laboratories Inc., St. Louis, Missouri) contrast by
ower injector (MedRad, Indianola, Pennsylvania) at a rate
f 10 ml/s. The pulse sequence used was a single-shot
radient echo sequence with saturation-recovery magneti-
ation preparation for T1 weighting and linear k-spacing.
he parameters were set to repetition time/echo time flip
ngle of 2.4 ms/1.2 ms/18° and a slice thickness of 10 mm.
ixty images per slice location were acquired with a spatial
esolution of 2 to 3 mm. Simulated stress imaging was
erformed using an infusion of adenosine at a concentration
f 140 g/kg/min for 4 min. First-pass perfusion imaging
as obtained at the end of injection, and after 3 min 45 s of
denosine infusion. Subsequently, the scan was repeated
uring resting conditions, at least 5 min after the adenosine
nfusion had been stopped. Perfusion was then determined
n 3 LV short-axis slices. The first slice was located closer to
he base of the heart, the second in the middle of the LV,
nd the third slice closer to the apex just distal to the base
f the papillary muscles. Patients were asked to perform
hallow breathing for the duration of the scan to minimize
espiratory motion. Blood pressure, heart rate, and any
erious adverse reactions caused by the simulated stress
hroughout the CMR imaging examination were monitored
y a physician and nursing personnel.
For cinemagnetic resonance imaging, an electrocardiogram-
ated breath hold, segmented truefisp sequence was used with
T/TE/flip angle 33 ms/6 ms/25°. In-plane spatial resolution
f the cine sequence was 2 mm  1.4 mm with a slice
hickness and increment of 10 mm. The temporal resolution
as 30 to 50 ms with 14 to 16 cardiac phases per plane.
omparisons between MPR, FFR, and QCA. First,
PR values for all coronary segments, as described in the
receding, were plotted and compared with QCA and FFR
ata without any guidance (blind analysis) from the angio-
raphic data regarding specific target segments. The mini-
um MPR values for the corresponding coronary segment
n each slice (base, middle, and apex) were averaged and
sed for comparison.
In a second analysis, the location of the stenosis defined
y QCA was used to guide the selection of MPR values
rom specific myocardial slices corresponding to the stenosis
ocation (proximal, middle, or distal). This allowed a more
tenosis-specific comparison among MPR, QCA, and FFR
ssessments. Thus, in an ostial stenosis we considered MPR
alues from all 3 slices, whereas for proximal and middle 0ocated stenosis, only MPR values from the middle and
pical slices were averaged for comparison. As in the blind
nalysis, the lowest MPR from an artery’s territory was used
rom each pertinent slice. At least 2 MPR values from
ifferent slices were averaged for comparison. The exception
ccurred with apical stenosis, of which the 2 lowest MPR
alues from the artery’s territory were averaged. It is impor-
ant to note that, although the selection of MPR values was
ot blinded to QCA measurements, the calculation of MPR
or each sector (8 per slice) was automatically calculated
sing a computerized workstation by analysts unaware of
he angiographic data.
tatistical analysis. Data are presented as mean  stan-
ard deviation. Frequencies are presented as percentage.
eceiver-operating curve (ROC) analysis was performed
sing MedCalc (MedCalc Software, Mariakerke, Belgium)
o define sensitivity, specificity, and optimal cutoff values of
PR to determine anatomic (50% DS) and hemodynam-
cally (FFR 0.75) significant CAD. Positive predictive
alue (PPV) and negative predictive value (NPV) were also
erived using the MPR cutoff from the ROC analysis. The
5% confidence intervals (CIs) for sensitivity and specificity
ere analyzed using SAS 9.1 (SAS Institute Inc., Cary, North
arolina) with PROC SURVEYFREQ and PROC SUR-
EYMEANS. Analysis of variance single factor analysis was
lso performed on the MPR data using an FFR of 0.75 and
S of 50% as cutoff for those patients with CAD.
esults
emographics of the study population are reported in Table
. There were no significant demographic differences be-
ween patients with single-vessel CAD who had an FFR of
0.75 or 0.75. One patient was excluded because of
ire-induced coronary spasm during FFR measurements.
ix patients were excluded because of inadequate MRI
mage quality for quantitative assessment. There were no
omplications related to CMR procedures, and all patients
olerated the procedure well. The MPR and FFR values
ere compared in 44 coronary segments, and comparison
etween QCA and MPR involved 108 segments from 30
atients. Figure 2 illustrates a typical correlation between
PR, angiography, and FFR. A typical appearance of a
erfusion defect during stress MRI is illustrated in Figure 3.
lind MPR comparisons with FFR and QCA. The
PR and FFR values were compared in 44 corresponding
oronary segments (Table 2). The average MPR in seg-
ents with FFR 0.75 (n  14) was 1.50  0.45 and with
FR 0.75 (n  30) was 2.07  0.66 (p  0.0059). The
OC curve demonstrated an MPR cutoff of 1.97 that was
5.7% sensitive (95% CI 57.2 to 97.8) and 60.0% specific
95% CI 40.6 to 77.3) with a PPV of 50% and an NPV of
0% in predicting an FFR of 0.75.
The MPR and QCA data were compared in 108
orresponding coronary segments (Table 2). The average
PR in segments with 50% DS (n  47) was 1.54 .51 and with 50% DS (n  61) was 2.02  0.77 (p 
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.12 that was 85.1% sensitive (95% CI 71.7 to 93.8) and
9.3% specific (95% CI 27.1 to 52.7) with a PPV of 63%
Figure 2 Correlation Between MPR and Quantitative Coronary
The myocardial perfusion reserve (MPR) data (left panel) are reported in graphics
sponding to left ventricle blood pool). Purple and green lines represent the fitting
slice at the bottom of each graphic. Rest and stress flow are also reported in the
average MPR of 1.79, which corresponds to the left circumflex artery territory. Cor
marginal branch of the left circumflex artery, which had a fractional flow reserve of
tours. Perfusion magnetic resonance imaging images at both stress and rest are s
visualized in the stress image, and was only detected by the quantitative method.
Please see the Appendix for accompanying video.
tudy Population
Table 1 Study Population
Demographics
Age, yrs 65  11
Male, n (%) 16 (53%)
Hypertension, n (%) 24 (80%)
Diabetes mellitus, n (%) 7 (23%)
Smoking history, n (%) 6 (20%)
Hyperlipidemia, n (%) 17 (57%)
Peripheral vascular disease, n (%) 3 (10%)
Ejection fraction, per CMR (%) 57  13
Creatinine, mg/dl 0.98  0.36
Coronary anatomy, n (%)
No significant disease 1 (3%)
1-vessel disease 8 (27%)
2-vessel disease 9 (30%)
3-vessel disease 10 (33%)
Left main disease 2 (7%)
Medications, n (%)
Beta-blockers 21 (70%)
Angiotensin blockers 18 (60%)
Statins 19 (63%)
Calcium-channel blockers 6 (20%)
Nitrates 12 (40%)
MR  cardiac magnetic resonance.nd an NPV of 84% in predicting 50% DS CAD. The
verage MPR in segments with 70% DS (n  14) was
.46  0.53 and with 70% DS (n  94) was 1.86 
.72 (p  0.047). The ROC curve demonstrated an MPR
utoff of 1.84 that was 85.7% sensitive (95% CI 57.2 to
7.8) and 46.8% specific (95% CI 36.4 to 57.4) with a
PV of 19% and NPV of 96% in predicting a 70% DS
AD.
In segments that were most likely to have significant
AD, i.e., FFR0.75 and50% DS (n 12), the average
PR was 1.56  0.46. In segments that were least likely to
ave significant CAD, i.e., FFR 0.75 and 50% DS
n  20), the average MPR was 2.2  0.72.
tenosis-specific correlation of MPR with FFR and
CA. A total of 44 segments were analyzed for the
omparison between MPR and FFR (Table 2). The average
PR in segments with FFR 0.75 (n  14) was 1.54 
.36 and with FFR 0.75 (n  30) was 2.11  0.68 (p 
.0054). The ROC analysis demonstrated an MPR cutoff of
.04, which was 92.9% sensitive (95% CI 77.9 to 100.0) and
6.7% specific (95% CI 32.8 to 80.6) with a PPV of 50%
nd an NPV of 94% in predicting a significant FFR (0.75)
Fig. 4).
A total of 108 segments were analyzed for the comparison
etween MPR and QCA (Table 2). The average MPR in
egments with 50% DS (n  47) was 1.54  0.49 and
ith50% DS (n 61) was 2.13 0.80 (p 0.001). The
graphy
ividual slices of cardiac magnetic resonance (CMR) (S1 to S8; first graphic corre-
for rest and stress, respectively. The MPR values (Pr) are depicted for each
aph, with each bar corresponding to 1 CMR slice. Note that slice S4 shows an
ngiography (middle bottom panel) revealed a 65% stenosis in the first obtuse
Middle upper panel shows the middle CMR slides with the quantitative con-
in the right panels. It is important to note that the perfusion defect was not
diameter stenosis; FFR  fractional flow reserve.Angio
for ind
curves
bar gr
onary a
0.65.
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August 7, 2007:514–22 Quantitative Perfusion CMR Versus FFR to Assess CADOC analysis demonstrated an MPR cutoff of 2.04 that was
5.1% sensitive (95% CI 71.1 to 99.2) and 49.2% specific
95% CI 33.6 to 64.8) with a PPV of 59% and an NPV of
3% in predicting significant (50% DS) CAD (Fig. 5). The
verage MPR in segments with 70% DS (n  14) was
.40  0.38 and with 70% DS (n  94) was 1.94  0.76
p 0.01). The ROC analysis demonstrated an MPR cutoff
f 1.85 that was 92.9% sensitive (95% CI 66.1 to 98.8) and
0% specific (95% CI 39.5 to 60.5) with a PPV of 22% and
n NPV of 98% in predicting significant (70% DS) CAD.
In segments that were most likely to be hemodynamically
ignificant, according to the invasively derived data, i.e.,
FR 0.75 and 50% DS (n  12), the average MPR was
.60  0.34. In segments that were least likely to have
ignificant CAD, i.e., FFR 0.75 and 50% DS (n  20),
he average MPR was 2.25  0.73.
Figure 3 MRI Rest and Stress Perfusion Images (Middle Slices
The stress image shows the perfusion defect in the inferior cardiac wall (lower sig
artery. There is no perfusion defect observed in the magnetic resonance imaging (
mid perfusion MRI images at rest and stress.
Please see the Appendix for accompanying video.
ummary of Blinded andtenosis-Specific MPR Data
Table 2 Summary of Blinded andStenosis-Specific MPR Data
Blinded MPR
Stenosis-Specific
MPR
FFR 0.75 1.50 0.45* 1.54 0.36*
FFR 0.75 2.07 0.66 2.11 0.68
50% DS 1.54 0.51* 1.54 0.49*
50% DS 2.02 0.77 2.13 0.80
70% DS 1.46 0.53* 1.40 0.38*
70% DS 1.86 0.72 1.94 0.76
FFR 0.75  50% DS 1.56 0.46* 1.60 0.34*
FFR 0.75  50% DS 2.2 0.72 2.25 0.73
FFR 0.75  70% DS 1.49 0.46* 1.56 0.29*
FFR 0.75  70% DS 2.09 0.66 2.14 0.68s
p  0.05 indicates comparison between each category.
DS  diameter stenosis; FFR  fractional flow reserve; MPR  myocardial perfusion reserve.iscussion
he present results suggest that quantitative CMR can be
afely used to determine the hemodynamic significance of
oronary stenosis and to exclude the presence of significant
AD with a high degree of accuracy. Beyond the ability of
MR to detect the presence of ischemia (10,11), these
ndings support the hypothesis that MPR represents a
tenosis-specific measure of the functional significance of
AD. Cardiac magnetic resonance could therefore be used
s a highly sensitive screening tool to exclude hemodynam-
cally significant CAD. Likewise, CMR, with its higher
patial resolution compared with single-photon emission
omputerized tomography (SPECT) and its ability to si-
ultaneously evaluate myocardial viability, mechanics using
agging or phase-based techniques, and hemodynamics,
ould be used synergistically with multislice computerized
omographic angiography to further stratify patients who
ave been identified with ambiguous coronary stenosis (27).
Myocardial perfusion reserve, similar to other approaches
hat use adenosine as the pharmacologic stimuli, may be
ffected by endothelial dysfunction and the microcirculation
tatus (28–32). Thus, the relatively lower specificity of
PR compared with both FFR and QCA is likely associ-
ted with the high prevalence of hypertension, diabetes, and
yslipidemia, which are all known risk factors for impaired
ndothelium and myocardial flow-mediated dependent va-
odilation (33). In addition, there were 2 vessels with
ignificant CAD in 73% of the patients. In the present
tudy, side branches were also included and coronary seg-
ents supplying small myocardium territories compared.
et, MPR showed high degrees of agreement with both
FR and QCA. Although the FFR has been shown to be
rker image; arrows) corresponding to significant disease in the right coronary
age at rest. The perfusion defect can be appreciated in the video files of the)
nal, da
MRI) imtenosis specific and an accurate determinant of the need for
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nced by microvascular disease resulting in elevated values
espite significant epicardial CAD (34,35). Discrepancy
etween QCA data and physiologic measurements has been
nown since the early studies comparing CFR and QCA
36,37). The possibility of using other pharmacologic
gents, such as dobutamine, makes CMR an attractive
oninvasive test for patients who are not candidates for
FR, FFR, or other adenosine-based ischemia tests (38).
According to the present study, which includes a stable
opulation, a patient with a normal MPR (2.04) in all
oronary segments has a very low probability of having
emodynamically significant CAD. Whether CMR can
e used as a guide for therapeutic decision-making in
atients with known CAD remains to be evaluated in
uture studies with a larger patient population and
ong-term follow-up (39).
The MPR cutoff values observed in the present study
orrelated well with previously reported significant CFR
alues observed in patients with CAD (1,40). Serruys et al.
Figure 4 Sensitivity and Specificity of MPR to Detect CAD Wit
Graphics showing sensitivity (Sens), specificity (Spec), and predictive values of my
ating curve analysis to detect coronary artery disease (CAD) with fractional flow res
evaluated by Welch approximation for unequal variances from the independent-sam
Figure 5 Sensitivity and Specificity of MPR to Detect CAD Wit
Graphics showing sensitivity, specificity, and predictive values of MPR using a cuto
50% DS. Heterogeneity of variance in MPR levels correlated with percentage dia
from the independent-sample t test (p  0.0001). Abbreviations as in Figure 4.1) reported that a CFR 2.5 with a 35% DS had
xcellent short- and long-term outcomes after percutaneous
ransluminal coronary angioplasty. Di Mario et al. (40)
emonstrated that a CFR 2.0 with 35% DS was
ssociated with similar clinical outcomes. We and others
8,10,41,42) have shown the equivalence and direct corre-
ation between CFR and MPR values. Bedaux et al. (41)
eported an average MPR of 2.7  1 and CFR of 3.1  0.6
p  0.01) for nonstenosed vessels. Similar to the present
tudy findings, CFR has also been shown to strongly
orrelate with SPECT imaging and QCA (1,40,43,44).
The sensitivity and specificity of MPR in detecting CAD
hen FFR was used as the gold standard in the present
tudy compared favorably with earlier reports comparing
PECT with FFR (45–47). Hacker et al. (46) reported a
ensitivity of 80% and a specificity of 76% for SPECT in
etecting a target vessel with an FFR 0.75.
The MPR and QCA data, although correlated, were not
s strong as the correlation observed between MPR and
FR in the present study. Similar correlation coefficients
<0.75
al perfusion reserve (MPR) using a cutoff of 2.04 as determined by receiver-oper-
FFR) 0.75. Heterogeneity of variance in MPR levels correlated with FFR was
test (p  0.008).
0% DS
.04 as determined by receiver-operating curve analysis to detect CAD with
stenosis (DS) was evaluated by the Welch approximation for unequal variancesh FFR
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47,48). The present data correlate favorably with a recent
eta-analysis demonstrating a sensitivity of 89% and spec-
ficity of 65% when SPECT was compared with coronary
ngiography in detecting CAD (48). The limitation of
ngiography to determine the hemodynamic significance of
AD and its inability to define microvascular disease has
een previously reported (49) and likely explains some of the
iscordance between the noninvasive physiologic data and
CA.
The MPR cutoff values to exclude significant CAD in the
resent study are relatively higher than those previously
eported (11,50). The differences in patient demographics
nd degrees of epicardial and microvascular CAD between
tudies may explain these variations in MPR cutoff values.
he MPR values have recently been shown to be affected by
ender, age, and CAD risk factors (32).
The benefit of a noninvasive highly sensitive diagnostic
est to evaluate for and exclude physiologically significant
AD is unquestionable. Although further studies are
eeded to further establish the value of this imaging
pproach, the present data suggest that CMR through the
se of quantitative MPR can be used as an alternative
creening tool to both exclude and localize hemodynami-
ally significant CAD.
tudy limitations. The relatively small study population
epresents a potential limitation of this study. Our analysis,
owever, was based on coronary segments that included 44
nd 108 comparisons between MPR, FFR, and QCA,
espectively. Indeed, a larger study population would have
ncreased the statistical power and potentially improved the
pecificity of MPR compared with FFR and QCA. Al-
hough not pre-specified in the present study, a larger
ample size would allow subgroup analyses such as specific
valuation of patients with FFR between 0.75 and 0.8 and
hose with poor LV function.
The CMR images in 6 patients did not meet the minimal
equirements for quantitative analysis, which required ade-
uate images at rest and stress, as described in the Methods
ection. Suboptimal images in the present study were mainly
ssociated with motion artifact or inadequate timing of the
ontrast bolus. Therefore, the present study findings apply
nly to patients with optimal CMR image acquisition.
opefully, recent CMR technologic advancements such as
-T scanning, 32-channel scanners, and 32-element cardiac
rray coils will improve the CMR image quality and lead to
ewer patients with suboptimal image quality. Nevertheless,
he seminal data reported in this study comparing MPR and
FR for the first time suffice to demonstrate the potential
alue of MPR as an alternative noninvasive test to demon-
trate the physiologic significance of CAD.
Coronary flow reserve data would have been beneficial to
etermine the relative contribution of microvascular disease
o MPR values, and such data have been previously reported
8,10). However, CFR data alone do not provide an
bjective evaluation of epicardial CAD. The present study
as aimed at investigating the ability of MPR to reproduceFR data, the current gold standard method to assess the
emodynamic status of epicardial CAD with minimal
nfluence of microcirculation. The FFR is not absolutely
ndependent of the microcirculatory status, but, unlike
FR, microvascular dysfunction has an opposite effect on
FR measurements, i.e., it may increase FFR values. The
PR and FFR data correlated well in the present study
espite this peculiar aspect of FFR assessment of coronary
hysiology, which may further strengthen our conclusions
egarding the ability of perfusion MRI to evaluate CAD. To
ur knowledge, such a comparative study between MPR
nd FFR had not been done previously.
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